ALKEM
ALKEM LABORATORIES LTD.Healthcare
LTP
5,416
CHG · %
+84.5 (+1.58%)
VOL · TODAY
1.20L
PREV CLOSE
5,331.5
Today's range5,316 · 5,445
5,416
52-week range5,051 · 5,933.5
5,416
Loading candles…
Alkem Laboratories Ltd. is a pharmaceutical and nutraceutical company operating globally with a presence spanning over 50 years. It is engaged in research, development, manufacturing, and marketing across the pharmaceutical value chain. The company produces a range of products including pharmaceutical and nutraceutical products, branded generics, complex generics, and biosimilars. Alkem holds a dominant market position in acute therapy areas, particularly in anti-infectives, where it has maintained leadership for more than 15 years. It is recognized as the fifth-largest pharmaceutical company in India. No information on incorporation details, founders, key management, subsidiaries, or stock exchange listings is available.
This page is a live market overview for ALKEM LABORATORIES LTD. (ALKEM) on the NSE. As a listed security, ALKEM LABORATORIES LTD. is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ALKEM before placing trades on tick2trade.
As of the latest feed, ALKEM last traded at ₹5,416 on NSE, up ₹84.5 (1.58%) from the previous close of ₹5,331.5. Today's session range is ₹5,316 – ₹5,445, against a 52-week band of ₹5,051 – ₹5,933.5. Traded volume today stands at 1.20L shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, a near-the-money option chain snapshot, recent market headlines, upcoming corporate events for ALKEM in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ALKEM is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ALKEM LABORATORIES LTD. before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ALKEM. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ALKEM option chain page linked from this overview.
// similar in healthcare323 total